Get startedLog in
    Picture of Quantum Genomics SA logo

    ALQGC — Quantum Genomics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Quantum Genomics Ends Collaboration With Qilu On Firibastat In China

    Picture of Quantum Genomics SA logoQuantum Genomics SA
    20/04/2021 07:02
    April 20 (Reuters) - Quantum Genomics SA  ALQGC.PA :
    * QUANTUM GENOMICS ANNOUNCES THE END OF ITS COLLABORATION
WITH
QILU FOR THE DEVELOPMENT AND COMMERCIALIZATION OF FIRIBASTAT IN
CHINA
    * QUANTUM GENOMICS AND QILU PHARMACEUTICAL DID NOT SUCCEED
TO
ALIGN THEIR VIEW REGARDING FIRIBASTAT DEVELOPMENT.
    * REMAINS CONFIDENT TO FURTHER DEVELOP ITS WORLDWIDE
COVERAGE WITH
SIGNING OF NEW PARTNERSHIPS WHICH SHOULD BENEFIT TO ALL
STAKEHOLDERS
    * RECOVERS ITS RIGHTS FOR CHINESE MARKET AND REOPENS
DISCUSSIONS
WITH INTERNATIONAL PHARMA COMPANIES FOR THIS MARKET

Source text for Eikon:  ID:nGNX1svs2j 
Further company coverage:  ALQGC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Quantum Genomics SA

    See all news